Supplementary Figure S3:

Aktie "Supplementary Figure S3:"

N/A

Protected

Studienjahr: 2022

Info

Herunterladen

Protected

Academic year: 2022

Aktie "Supplementary Figure S3:"

Copied!

Wird geladen.... (Jetzt Volltext ansehen)

Jetzt herunterladen ( 1 Seite )

Volltext

(1)

Supplementary Figure S3: Gene Ontology (GO) terms enriched among transcripts differentially expressed in Heterorhabditis bacteriophora (Hb) and Metarhizium anisopliae (Ma) treatments that were shared with treatments A) Cry3Bb1 and B) Gpp34/Tpp35Ab1. Significantly

overrepresented GO terms are shown within categories biological process (BP) and cellular component (CC) (FDR ≤ 1.0E^-5) and molecular function (MF) at level 2 (FDR ≤ 1.0E^-7; grey bars). Categories listed by GO ID and GO term. Number of transcripts encoding each PFAM domain within each functional category are indicated (black bars).

A) B)

Referenzen

Jetzt herunterladen ( DOCX - 1 Seite - 289.76 KB )

ÄHNLICHE DOKUMENTE

Supplementary Figure S4:

DRONC NRRRIGAEKDSKSLIHLFQELNFTI-FP---YGNVNQDQFFKLLTMVTSSSYVQNTECFVMVLMTHGNSV 56 XP_028140498.1 FPYRNGALVDDANLKALFEQMGGWDLDC---YHNKTALEMIMLIQKFAG-EGKPDYDICCMIIMSHGGEM

Supplementary Figure S5:

Two baculovirus inhibition of apoptosis protein repeat domains (BIR1 and BIR2) and RING finder domains characteristic of IAP family 1 proteins are underlined, and cysteine

Supplementary Figure 1

Nuclear size estimation of PC3 xenograft sections. Nuclear size assessment

Supplementary Figure 2

BSCs plot obtained from an in vivo prostate tumour model pre-and-post 24 hours after USMB and HT treatment.. A representative plot of the measured BSC and its best- fit

Supplementary Figure 1

*Underlines indicate the restriction enzyme sites. Supplementary

Supplementary Figure legends

HeLa cells were exposed to etop 200 nM, campto 20 nM or MMC 100 nM for 24 h or 8 h, and analyzed by immunofluorescence microscopy with antibodies directed against H2AX and

Supplementary Figure 1a:

Supplementary Figure 1c: Conceptual model for factors contributing to medication adherence in adults with chronic, non-communicable conditions with asymptomatic

Supplementary Figure Captions Supplementary Figure 1.

Multimodal assessment of results achieved after proximal optimization technique (POT) in provisional. A,B) View of well apposed stent proximal to the bifurcation by direct

ÄHNLICHE DOKUMENTE

Supplementary Table S3:

Supplementary Figure S1:

Supplementary Figure S2:

Supplementary Figure S6:

Supplementary Figure S7:

Supplementary Figure S1.